Zymeworks Stock (NASDAQ: ZYME) stock price, news, charts, stock research, profile.
You can purchase shares of Zymeworks (NASDAQ:ZYME) through any online brokerage.
Other companies in Zymeworks’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Arcutis Biotherapeutics (NASDAQ:ARQT) and Prothena Corp (NASDAQ:PRTA).
Zymeworks has a consensus price target of $19.57.
The stock price for Zymeworks (NASDAQ: ZYME) is $12.4902 last updated September 24, 2024 at 4:37 PM EDT.
There are no upcoming dividends for Zymeworks.
Zymeworks’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Zymeworks.
Zymeworks is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.